TP53 and ovarian serous adenocarcinoma: A large-scale study of high-grade serous ovarian cancer (HGSOC) by The Cancer Genome Atlas (TCGA) group characterized HGSOC as TP53-mutation enriched (96%) with aberrations of genome-wide somatic gene copy numbers.